# Nchroma Bio

**Canonical:** https://apis.io/providers/nchroma-bio/  
**Website:** https://www.nchromabio.com  
**APIs profiled:** 0

nChroma Bio is a genetic medicines company developing durable in vivo therapies by pairing best-in-class genetic cargoes, including epigenetic editing approaches, with targeted delivery technologies for diseases of significant unmet need. Headquartered at 201 Brookline Avenue in Boston, Massachusetts, the company is backed by DCVC and GV. This is a corporate research and therapeutics organization; as of this enrichment pass it publishes no public developer API, documentation portal, SDKs, or machine-readable API surface.

## Kin Score — 7.6 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 7.6).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Nchroma Bio Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Genetic Medicines, Epigenetic Editing, Therapeutics, Life Sciences, Drug Discovery

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/nchroma-bio/). Scores are computed from the provider's own public artifacts under a published rubric.